Disciplined Investments, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Disciplined Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$185.01 - $212.05 $370 - $424	2 Added 66.67%	5 $0
Q1 2023 May 10, 2023	SELL	$182.66 - $235.53 $182 - $235	-1 Reduced 25.0%	3 $0
Q4 2022 Feb 01, 2023	SELL	$185.53 - $241.31 $185 - $241	-1 Reduced 20.0%	4 $0
Q3 2022 Nov 03, 2022	BUY	$138.54 - $232.0 $415 - $696	3 Added 150.0%	5 $1,000
Q2 2022 Aug 09, 2022	SELL	$120.42 - $169.29 $120 - $169	-1 Reduced 33.33%	2 $0
Q1 2022 Apr 22, 2022	BUY	$127.18 - $173.91 $381 - $521	3 New	3 $0

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.